A Dark Vector Cognition product

Item 5. OTHER INFORMATION

2K characters. Original on sec.gov ·

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading Arrangements

In the quarter ended March 27, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement for the purchase or sale of our securities, within the meaning of Item 408 of Regulation S-K except the following:

●In the quarter ended March 27, 2026, Aaron Stucki, President, Transportation Solutions, adopted a plan for the sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Mr. Stucki’s plan was adopted on February 4, 2026 and expires on December 31, 2026, and provides for the potential (i) exercise of stock options and associated sale representing up to 27,500 ordinary shares, with such sale to occur no earlier than May 6, 2026, (ii) sale of up to 3,000 ordinary shares, with such sale to occur no earlier than May 6, 2026, (iii) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than June 1, 2026, (iv) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than July 1, 2026, (v) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than August 1, 2026, (vi) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than October 1, 2026, (vii) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than November 1, 2026, and (viii) sale of up to 1,000 ordinary shares, with such sale to occur no earlier than December 1, 2026.

The trading plan described above was entered into during an open insider trading window and was in compliance with our insider trading policies and procedures. Actual sale transactions will be disclosed publicly in filings with the SEC in accordance with applicable securities laws, rules, and regulations.

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS